Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings
Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro
Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines
Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy
Activation of dendritic cells by local ablation of hepatocellular carcinoma
Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma
Natural-killer cells and dendritic cells: „l’union fait la force“
Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials
Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
[Study of Newcastle disease virus killing hepatocellular carcinoma cells in vitro]
Vaccine therapy for non-Hodgkin’s lymphoma and other B-cell malignancies
[Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma]
[The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte]
Chaperone-rich cell lysates, immune activation and tumor vaccination